Literature DB >> 18756632

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.

.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18756632      PMCID： PMC4781221     

Source DB:  PubMed          Journal:  IARC Monogr Eval Carcinog Risks Hum        ISSN： 1017-1606


× No keyword cloud information.
  49 in total

1.  Hormone therapy and ovarian cancer: incidence and survival.

Authors:  Karen J Wernli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2008-02-09       Impact factor: 2.506

Review 2.  Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.

Authors:  Gary D Friedman; Natalia Udaltsova; James Chan; Charles P Quesenberry; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

3.  Impact of menstrual and reproductive factors on breast cancer risk in Tunisia: a case-control study.

Authors:  Awatef Msolly; Olfa Gharbi; Slim Ben Ahmed
Journal:  Med Oncol       Date:  2013-02-02       Impact factor: 3.064

4.  Interfacial nano-biosensing in microfluidic droplets for high-sensitivity detection of low-solubility molecules.

Authors:  Maowei Dou; José Mireles García; Sihui Zhan; XiuJun Li
Journal:  Chem Commun (Camb)       Date:  2016-01-13       Impact factor: 6.222

5.  Building a culture of life by embracing the feminine genius: A message to Catholic women in health care.

Authors:  Susan Caldwell
Journal:  Linacre Q       Date:  2017-11-08

Review 6.  The treatment of climacteric symptoms.

Authors:  Olaf Ortmann; Claus Lattrich
Journal:  Dtsch Arztebl Int       Date:  2012-04-27       Impact factor: 5.594

7.  Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.

Authors:  Xin Grevers; Anne Grundy; Abbey E Poirier; Farah Khandwala; Matthew Feldman; Christine M Friedenreich; Darren R Brenner
Journal:  CMAJ Open       Date:  2016-12-12

Review 8.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

9.  Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.

Authors:  E V Kane; L Bernstein; P M Bracci; J R Cerhan; L Costas; L Dal Maso; E A Holly; C La Vecchia; K Matsuo; S Sanjose; J J Spinelli; S S Wang; Y Zhang; T Zheng; E Roman; A Kricker
Journal:  Ann Oncol       Date:  2012-09-11       Impact factor: 32.976

10.  Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy.

Authors:  Li Li; Jia Ji; Jian-Bing Wang; Mayineur Niyazi; You-Lin Qiao; Paolo Boffetta
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.